A detailed history of Jpmorgan Chase & CO transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 71,571 shares of AMPH stock, worth $3.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
71,571
Previous 140,454 49.04%
Holding current value
$3.62 Million
Previous $6.17 Million 53.59%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$38.65 - $43.48 $2.66 Million - $3 Million
-68,883 Reduced 49.04%
71,571 $2.86 Million
Q1 2024

May 10, 2024

BUY
$42.85 - $63.45 $2.84 Million - $4.2 Million
66,229 Added 89.23%
140,454 $6.17 Million
Q4 2023

Feb 12, 2024

SELL
$44.49 - $62.93 $281,354 - $397,969
-6,324 Reduced 7.85%
74,225 $4.59 Million
Q3 2023

Nov 14, 2023

SELL
$45.51 - $65.0 $150,137 - $214,435
-3,299 Reduced 3.93%
80,549 $3.7 Million
Q2 2023

Aug 11, 2023

SELL
$35.77 - $58.38 $1.21 Million - $1.98 Million
-33,919 Reduced 28.8%
83,848 $4.82 Million
Q1 2023

May 18, 2023

BUY
$27.99 - $37.92 $1.34 Million - $1.81 Million
47,801 Added 68.32%
117,767 $4.42 Million
Q1 2023

May 11, 2023

SELL
$27.99 - $37.92 $1.23 Million - $1.66 Million
-43,787 Reduced 38.49%
69,966 $2.62 Million
Q4 2022

Feb 13, 2023

SELL
$27.93 - $31.27 $2.96 Million - $3.31 Million
-105,930 Reduced 48.22%
113,753 $3.19 Million
Q3 2022

Nov 14, 2022

BUY
$27.56 - $37.75 $69,644 - $95,394
2,527 Added 1.16%
219,683 $6.17 Million
Q2 2022

Aug 11, 2022

BUY
$29.79 - $42.29 $3.83 Million - $5.44 Million
128,688 Added 145.46%
217,156 $7.56 Million
Q1 2022

May 11, 2022

SELL
$22.96 - $36.45 $506,199 - $803,613
-22,047 Reduced 19.95%
88,468 $3.18 Million
Q4 2021

Feb 10, 2022

SELL
$18.14 - $23.29 $1.15 Million - $1.47 Million
-63,175 Reduced 36.37%
110,515 $2.57 Million
Q3 2021

Nov 12, 2021

BUY
$17.83 - $21.49 $3.1 Million - $3.73 Million
173,690 New
173,690 $3.3 Million

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $2.48B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.